VSee Health(VSEE.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
VSee Health
VSEE.US
VSee Health, Inc. provides telehealth care solutions in the United States. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. It also provides telehealth software building blocks, such as patient engagement, clinician staffing, remote physical exam and remote patient monitoring, and AI for telesitter and telenursing solutions; data connectors; and workflow templates.
63.95 B
VSEE.USMarket value -Rank by Market Cap -/-

Financial Score

20/01/2026 Update
C
Health Care TechnologyIndustry
Industry Ranking24/47
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE2466.80%A
    • Profit Margin-69.81%E
    • Gross Margin52.08%B
  • Growth ScoreB
    • Revenue YoY77.78%A
    • Net Profit YoY82.42%A
    • Total Assets YoY-25.26%E
    • Net Assets YoY-217.16%E
  • Cash ScoreB
    • Cash Flow Margin-143.26%D
    • OCF YoY77.78%A
  • Operating ScoreB
    • Turnover0.66B
  • Debt ScoreE
    • Gearing Ratio129.80%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    VSee Launches AI-Driven Rural Health Transformation Platform, Targeting Millions in Recaptured Revenue Per Hospital | VSEE Stock News

    VSee Health, Inc. (Nasdaq: VSEE) has launched an AI-driven Rural Health Transformation Solution aimed at enhancing access and financial sustainability for rural hospitals. This modular platform addresses specialist shortages and revenue leakage, potentially recapturing up to $5.3 million annually by reducing avoidable patient transfers. The solution integrates telehealth, AI clinical automation, and aligns with federal rural health initiatives. VSee aims to improve local healthcare delivery while preserving community revenue. Investors can learn more at the 2026 J.P. Morgan Healthcare Conference.

    StockTitan·
    US
    VSEE
    -0.90%
    StockTitan·
    US
    VSEE
    -0.90%

    VSee Health Inc. Held Annual Shareholder Meeting

    VSee Health Inc. held its annual shareholder meeting on December 30, 2025, where stockholders elected Dr. Milton Chen and Dr. Imoigele Aisiku to the board of directors. They also approved the 2025 Equity Incentive Plan and a proposal to adjourn the meeting if necessary.

    Reuters·
    US
    VSEE
    -0.90%
    Reuters·
    US
    VSEE
    -0.90%

    VSee Health Lowers Quorum Requirement Ahead of 2025 Meeting

    VSee Health, Inc. announced an amendment to its bylaws, reducing the quorum requirement for stockholder meetings to one-third of voting power. This change, effective retroactively for the 2025 Annual Meeting, aims to facilitate official business with fewer shareholders. Despite this, VSEE stock is rated as Hold with a $0.54 target, facing challenges due to weak financials and bearish technical indicators.

    Tip Ranks·
    US
    VSEE
    -0.90%
    Tip Ranks·
    US
    VSEE
    -0.90%

    VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025 | VSEE Stock News

    VSee Health, Inc. (NASDAQ:VSEE) has postponed its 2025 Annual Meeting of Stockholders from December 15 to December 30, 2025, due to insufficient shares present to constitute a quorum. The meeting will be held via live webcast. Stockholders are encouraged to vote by December 29, 2025. No changes have been made to the proposals to be voted on. The company continues to solicit votes and emphasizes the importance of stockholder participation.

    StockTitan·
    US
    VSEE
    -0.90%
    StockTitan·
    US
    VSEE
    -0.90%

    VSee Health Files Certificate for Series B Stock

    VSee Health filed a Certificate of Designation for Series B Convertible Preferred Stock, effective December 5, 2025. This stock ranks senior to common stock and junior securities, on parity with Series A preferred stock, and junior to future senior securities. It is convertible to common stock under certain conditions and carries specific dividend rights, impacting capital structure and shareholder value. Analysts rate VSEE stock as Hold with a $0.54 price target, noting weak financial performance and bearish technical analysis.

    Tip Ranks·
    US
    VSEE
    -0.90%
    Tip Ranks·
    US
    VSEE
    -0.90%
    © 2026 Longbridge｜Disclaimer